Effects of jingyuankang capsules on leukocyte level in AIDS patients.

Abstract

OBJECTIVE:

To observe the therapeutic effects of Jingyuankang capsules for leukopenia in AIDS patients.

METHODS:

In this randomized double-blind trial, 58 patients orally took Jingyuankang capsule, analog Leucogen tablet and the HAART (highly active anti-retroviral therapy) drugs, and the other 58 patients took Leucogen tablet, analog Jingyuankang capsule and the HAART drugs all for 6 months, during which the peripheral hemogram was periodically examined to observe the therapeutic effects of Jingyuankang capsule for leukopenia of the AIDS patients.

RESULTS:

With good therapeutic effect for leukopenia of the AIDS patients, Jingyuankang capsule can enhance leukocyte level as effective as Leucogen tablet in treating grade I and grade II leukopenia, and more effectively than Leucogen tablet in treating grade III leukopenia. No toxic side-effects and adverse reactions were found during the treatment and in the follow-up visit.

CONCLUSION:

Jingyuankang capsule can effectively treat leukopenia of the AIDS patients.

• Authors: Shi-Qing Jiang, Hong-Xin Sun, Ying-Min Xu, Yan-Ling Jiang, Jun-Wen Pei, Hong-Ling Wang
• Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan (J Tradit Chin Med) Vol. 31 Issue 1 Pg. 32-5 (Mar 2011) ISSN: 0255-2922 [Print] China
• PMID: 21563503 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)

Chemical References

• Drugs, Chinese Herbal

Topics

• Acquired Immunodeficiency Syndrome (drug therapy, immunology)
• Adolescent
• Adult
• Aged
• Drugs, Chinese Herbal (therapeutic use)
• Female
• Humans
• Leukocytes (drug effects, immunology)
• Male
• Middle Aged
• Young Adult